SCHEMBL6857598

SCHEMBL6857598

CCC(=O)NC(CC(=O)O)c1ccc(C)cc1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.59
NFE2L2 Q16236 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.58
ALDH1A1 P00352 2/20 0.58
LMNA P02545 2/20 0.58
CYP26A1 O43174 2/20 0.57
POLB P06746 1/20 0.53
CTSA P10619 6/20 0.49
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 1/20 0.47
UTS2R Q9UKP6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6859171 0.87 SMN1; SMN2 (0.54) KEAP1NFE2L2SMN1; SMN2ALDH1A1LMNA
SCHEMBL6857593 0.86 SMN1; SMN2 (0.64) SMN1; SMN2ALDH1A1LMNACYP26A1POLB
SCHEMBL6857626 0.85 ALDH1A1 (0.55) KEAP1NFE2L2SMN1; SMN2ALDH1A1LMNA
SCHEMBL6859119 0.85 SMN1; SMN2 (0.53) KEAP1NFE2L2SMN1; SMN2ALDH1A1LMNA
SCHEMBL15654637 0.85 CYP26A1 (0.58) KEAP1NFE2L2SMN1; SMN2ALDH1A1LMNA
SCHEMBL28784050 0.84 SMN1; SMN2 (0.59) SMN1; SMN2ALDH1A1LMNAPOLBCTSA
SCHEMBL7362926 0.83 KEAP1 (0.53) KEAP1NFE2L2SMN1; SMN2ALDH1A1LMNA
SCHEMBL21476083 0.83 KEAP1 (0.53) KEAP1NFE2L2SMN1; SMN2ALDH1A1LMNA
SCHEMBL1138669 0.81 CYP26A1 (0.51) KEAP1NFE2L2SMN1; SMN2ALDH1A1LMNA
SCHEMBL15787300 0.81 CYP26A1 (0.54) KEAP1NFE2L2SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011098603-A1 1,2,3-TRIAZOLE-BASED PEPTIDOMIMETIC INTEGRIN INHIBITORS FOR THE DIAGNOSIS AND THERAPY OF TUMORS UNIVERSITA' DEGLI STUDI DI FIRENZE (IT) 2011-08-18 WO disclosed